Crohn’s disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?

od Minderhoud, Itta M, Samsom, Melvin, Oldenburg, Bas
izdano v World J Gastroenterol (2007)

C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease

od Koelewijn, Chantal L, Schwartz, Matthijs P, Samsom, Melvin, Oldenburg, Bas
Izdano 2008

Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study

od Opstelten, Jorrit L, Vaartjes, Ilonca, Bots, Michiel L, Oldenburg, Bas
izdano v Inflamm Bowel Dis (2019)

Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn’s colitis patients in the Netherlands

od van Rijn, Anne F, Fockens, Paul, Siersema, Peter D, Oldenburg, Bas
Izdano 2009

Prototype evaluation of a self-management Internet diary for patients with ulcerative colitis

od Snoei, Lucia, van Bodegraven, Ad, Oldenburg, Bas, Stijnen, Theo, Kaptein, Ad A
Izdano 2009

Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn’s disease: A meta-analysis

od Binion, David G, Louis, Edouard, Oldenburg, Bas, Mulani, Parvez, Bensimon, Arielle G, Yang, Mei, Chao, Jingdong
Izdano 2011

Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn’s disease and rheumatoid arthritis: Results of a systematic review

od Fidder, Herma H, Singendonk, Maartje MJ, van der Have, Mike, Oldenburg, Bas, van Oijen, Martijn GH
Izdano 2013

WNT-Pathway Activation in IBD-Associated Colorectal Carcinogenesis: Potential Biomarkers for Colonic Surveillance

od Claessen, Marian M. H., Schipper, Marguerite E. I., Oldenburg, Bas, Siersema, Peter D., Offerhaus, G. Johan A., Vleggaar, Frank P.
izdano v Cell Oncol (2010)

Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease

od Opstelten, Jorrit L., Plassais, Jonathan, van Mil, Saskia W. C., Achouri, Emna, Pichaud, Matthieu, Siersema, Peter D., Oldenburg, Bas, Cervino, Alessandra C. L.
izdano v Inflamm Bowel Dis (2016)

Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

od van Schaik, Fiona D. M., Gadaleta, Raffaella M., Schaap, Frank G., van Mil, Saskia W. C., Siersema, Peter D., Oldenburg, Bas, van Erpecum, Karel J.
Izdano 2012

MATISSE: a method for improved single cell segmentation in imaging mass cytometry

od Baars, Matthijs J. D., Sinha, Neeraj, Amini, Mojtaba, Pieterman-Bos, Annelies, van Dam, Stephanie, Ganpat, Maroussia M. P., Laclé, Miangela M., Oldenburg, Bas, Vercoulen, Yvonne
izdano v BMC Biol (2021)

Publisher Correction to: MATISSE: a method for improved single cell segmentation in imaging mass cytometry

od Baars, Matthijs J. D., Sinha, Neeraj, Amini, Mojtaba, Pieterman-Bos, Annelies, van Dam, Stephanie, Ganpat, Maroussia M. P., Laclé, Miangela M., Oldenburg, Bas, Vercoulen, Yvonne
izdano v BMC Biol (2021)

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands

od de Bock, Ellen, Filipe, Mando D, Meij, Vincent, Oldenburg, Bas, van Schaik, Fiona D M, Bastian, Okan W, Fidder, Herma F, Vriens, Menno R, Richir, Milan C
izdano v BMJ Open Gastroenterol (2021)

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance

od Mahmoud, Remi, Shah, Shailja C., Torres, Joana, Castaneda, Daniel, Glass, Jason, Elman, Jordan, Kumar, Akash, Axelrad, Jordan, Harpaz, Noam, Ullman, Thomas, Colombel, Jean-Frédéric, Oldenburg, Bas, Itzkowitz, Steven H.
izdano v Clin Gastroenterol Hepatol (2019)

Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers

od Hirdes, Meike M. C., Schwartz, Matthijs P., Tytgat, Kristien M. A. J., Schlösser, Noёl J., Sie-Go, Daisy M. D. S., Brink, Menno A., Oldenburg, Bas, Siersema, Peter D., Vleggaar, Frank P.
Izdano 2010

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases

od Mahmoud, Remi, Shah, Shailja C., ten Hove, Joren R., Torres, Joana, Mooiweer, Erik, Castaneda, Daniel, Glass, Jason, Elman, Jordan, Kumar, Akash, Axelrad, Jordan, Ullman, Thomas, Colombel, Jean-Frederic, Oldenburg, Bas, Itzkowitz, Steven H.
izdano v Gastroenterology (2018)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

od Simsek, Melek, Lissenberg‐Witte, Birgit I., van Riswijk, Milou L. M., Verschuren, Sander, Hoentjen, Frank, Oldenburg, Bas, Ponsioen, Cyriel Y., van der Woude, C. Janneke, van der Meulen, Andrea E., Pierik, Marieke, Dijkstra, Gerard, de Boer, Nanne K. H.
izdano v Aliment Pharmacol Ther (2019)

Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentr...

od van der Have, Mike, Oldenburg, Bas, Kaptein, Ad A., Jansen, Jeroen M., Scheffer, Robert C. H., van Tuyl, Bas A., van der Meulen-de Jong, Andrea E., Pierik, Marieke, Siersema, Peter D., van Oijen, Martijn G. H., Fidder, Herma H.
izdano v J Crohns Colitis (2016)

Corrigendum: Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospecti...

od van der Have, Mike, Oldenburg, Bas, Kaptein, Ad A, Jansen, Jeroen M, Scheffer, Robert C H, van Tuyl, Bas A, van der Meulen-de Jong, Andrea E, Pierik, Marieke, Siersema, Peter D, van Oijen, Martijn G H, Fidder, Herma H
izdano v J Crohns Colitis (2018)

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events

od Asscher, Vera E. R., van der Vliet, Quirine, van der Aalst, Karen, van der Aalst, Anniek, Brand, Eelco C., van der Meulen-de Jong, Andrea E., Oldenburg, Bas, Pierik, Marieke J., van Tuyl, Bas, Mahmmod, Nofel, Maljaars, P. W. Jeroen, Fidder, Herma H.
izdano v Int J Colorectal Dis (2020)